Early introduction of HMG-CoA reductase inhibitors could prevent the incidence of transplant coronary artery disease.
Kato
T
T
Department of Surgery II, Nagoya University School of Medicine, Nagoya, Japan.
Tokoro
T
T
Namii
Y
Y
Kobayashi
T
T
Hayashi
S
S
Yokoyama
I
I
Morimoto
S
S
Chan
M
M
Giannetti
N
N
Hunt
S A
SA
D000293:Adolescent; D000328:Adult; D000069059:Atorvastatin; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000453:epidemiology / Q000517:prevention & control*; D005229:Fatty Acids, Monounsaturated / Q000627:therapeutic use; D005260:Female; D000077340:Fluvastatin; D006084:Graft Rejection / Q000453:epidemiology; D016027:Heart Transplantation / Q000502:physiology; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D015994:Incidence; D007211:Indoles / Q000627:therapeutic use; D008148:Lovastatin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology / Q000517:prevention & control*; D017035:Pravastatin / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use; D019821:Simvastatin / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D005229:Fatty Acids, Monounsaturated; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007211:Indoles; D011758:Pyrroles; D014280:Triglycerides; D000077340:Fluvastatin; D002784:Cholesterol; D008148:Lovastatin; D000069059:Atorvastatin; D019821:Simvastatin; D017035:Pravastatin